Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
Shin Poong Pharm Clinical Trials
Determine Shin Poong Pharm Co Ltd go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.
A sample of Shin Poong Pharm Clinical Trials data
| Trial Title | Trial Identifier | Drug Name | Therapy Area | Indication | Trial Phase | Trial Status | Sponsor |
|---|---|---|---|---|---|---|---|
| Deserunt mollit sunt Lorem | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Pfizer Inc |
| Shinpoong Pharmaceutical Co., Ltd.’s “Loxfen CR Tablet (Loxoprofen Sodium) (after Modification)” (Loxoprofen Sodium Hydrate 102.15 Mg (Loxoprofen Sodium Anhydrous 90 Mg)) and Shinpoong Pharmaceutical Co., Ltd.’s “Loxpen Release in Healthy Adult Subjects for Bioequivalence Evaluation of CR Tablet (Loxoprofen Sodium) (Before Change)” (Loxoprofen Sodium Hydrate 102.15 Mg (Loxoprofen Sodium Anhydrous 90 Mg)), Randomized Assignment, II Groups, II Period, after Meals, Single Dose, Oral, Crossover Test | GDCT0474193 | Loxfen CR | Central Nervous System; Immunology; Musculoskeletal Disorders | Arthritis; Low Back Pain; Osteoarthritis; Rheumatoid Arthritis | Phase I | Planned | Shin Poong Pharm Co Ltd |
| Shinpoong Pharmaceutical Co., Ltd.'s "Roxfen CR Tablet (Loxoprofen Sodium) (after Change)" (Loxoprofen Sodium Hydrate 102.15 mg (Loxoprofen Sodium Anhydrous 90 mg)) and Shin Poong Pharmaceutical's "Roxfen Sodium Anhydrous" Healthy Adult Subjects to Explore and Evaluate the Pharmacokinetics and Safety of Cial Tablet (Sodium Loxoprofen) (Before Modification)” (102.15 mg of Loxoprofen Sodium Hydrate (90 mg as Loxoprofen Sodium Anhydrous)) Open, Randomized, Group 4, Single, Oral, Parallel Trial | GDCT0471442 | loxoprofen DR | Central Nervous System; Immunology; Musculoskeletal Disorders | Arthritis; Low Back Pain; Osteoarthritis; Rheumatoid Arthritis | Phase I | Planned | Shin Poong Pharm Co Ltd |
| Pilot Clinical Trial to Explore Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients | GDCT0458287 | (artesunate + pyronaridine) | Infectious Disease | Coronavirus Disease 2019 (COVID-19) | Phase II | Completed | Shin Poong Pharm Co Ltd |
Feature
GlobalData’s Clinical Trials database (CTDB) is a highly comprehensive source of Clinical Trials.
The database covers planned, ongoing, completed and terminated/suspended/withdrawn clinical trials.
Clinical Trials database provides intelligence on global clinical trials for all indications. The data is sourced from:
- 250+ clinical trial registries
- 200+ scientific and investor conferences, company pipelines, press releases, and SEC filings.
Benefit
The Clinical Trials database collects information on various parameters to provide a Clinical Trial overview as well as Clinical Trial details, Drug details, Patient details, Trial Results, Location(s)/Sponsor(s) and Contact Detail(s).
Access:
- Detailed trial information.
- Drug information.
- Patient information, including inclusion and exclusion criteria.
- Trial results, as reported in the public domain.
- Biomarkers used for patient stratification/selection & outcome measures.
- Enrolment parameters.
- Investigators involved in clinical trials.
- Trials sites and locations.
- Contact information.
Value
Competitive Activity – keep an eye on planned or ongoing trials, as well as the trials currently recruiting and who is sponsoring them.
Geographic Analysis - see where trials are being run.
Trend Analysis - view top sponsors, indications, phase, status and more with Trial Analytics.
Find information on trials contacts, as well as Site and Investigator information.
Get information on trial successes and failures.
Get intelligence on CROs engaged in clinical trials.
Use as a business development tool for CROs.
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer